A measure proposed by a group of senators Friday would give the FDA increased regulatory control over some compounding pharmacies. "This bill will enhance protections for patients taking compounded drugs and help prevent crises like last year's tragic meningitis outbreak," said Sen. Tom Harkin, D-Iowa.

Full Story:

Related Summaries